Post-Packaging pH-Responsive Peptide Conjugation Enhances Productive Transduction by Antibody-Guided Adeno-Associated Viral Vectors
Abstract Adeno-associated virus vectors are widely used for gene delivery, yet their functional efficiency is limited by multiple intracellular bottlenecks. Here, we develop a modular vector engineering strategy that combines antibody-guided cellular entry with site-specific capsid modification to enhance post-entry processes. By systematically introducing surface-exposed cysteine residues into a heparan sulfate-binding-deficient capsid, we identify a permissive position that enables efficient chemical conjugation without compromising capsid assembly while revealing strong serotype-dependent constraints on capsid engineering. Using this optimized backbone, we implement antibody-guided delivery and conjugate a membrane-inserting peptide through polyethylene glycol linkers to enhance the post-entry efficiency. Peptide conjugation significantly increases transgene expression across multiple cell types without increasing viral uptake, indicating improved intracellular processing. Dose−response analyses further reveal a threshold-dependent behavior, in which functional enhancement becomes evident only above a critical vector input, a phenomenon consistently observed across distinct antigen−antibody pairs and extended to therapeutic transgenes. Together, these findings define a flexible and generalizable capsid modification strategy that improves productive transduction independently of intrinsic capsid tropism and provides a practical framework for next-generation gene delivery vectors.
Authors
- Takako Eguchi Nakajima (ORCID: https://orcid.org/0000-0002-4589-2335)
- Akifumi Takaori‐Kondo (ORCID: https://orcid.org/0000-0001-7678-4284)
- Shojiro Inano (ORCID: https://orcid.org/0000-0003-0210-1158)
- Hiroyuki Morita (ORCID: https://orcid.org/0000-0003-0879-5576)
- Ayako Yokomizo (ORCID: https://orcid.org/0000-0002-8255-794X)
- Chiaki Suzuki (ORCID: https://orcid.org/0000-0002-3287-7857)
- Takeshi Sawada (ORCID: https://orcid.org/0009-0006-5153-7117)
- Yutaka Shimazu (ORCID: https://orcid.org/0000-0002-1604-7220)
Institutions
- Kyoto University (JP)
- Kitano Hospital (JP)
Publication Details
- Journal
- Molecular Pharmaceutics
- Published
- 2026-11-12
- DOI
- https://doi.org/10.1021/acs.molpharmaceut.6c00757
- Primary Topic
- Virus-based gene therapy research
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- Japan Agency for Medical Research and Development
- Japan Society for the Promotion of Science